All News Innoveren Scientific Inc.

Equities

IVRN

US4041243076

Market Closed - OTC Markets Other stock markets 02:57:09 2024-06-03 pm EDT			5-day change	1st Jan Change
0.0036 ^USD	-34.55%		-.--%	-96.90%

Jul. 02	Innoveren Scientific Inc. Announces Resignation of William Horne as Member of the Board of Directors	CI
Jun. 04	Innoveren Scientific Inc. announced that it has received $0.25 million in funding	CI

All News

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Innoveren Scientific Inc. Announces Resignation of William Horne as Member of the Board of Directors	Jul. 02	CI
Innoveren Scientific Inc. announced that it has received $0.25 million in funding	Jun. 03	CI
Innoveren Scientific : Announces Corporate Update - Form 8-K	May. 22	PU
Innoveren Scientific Announces 510(K) Submission to U.S. Federal Food and Drug Administration for Skindisc(Tm) Lite	Mar. 06	CI
Innoveren Scientific Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 15	CI
Innoveren Scientific Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	Nov. 15	CI
H-Cyte, Inc. has Changed its Name to Innoveren Scientific Inc	23-07-10	CI
Innoveren Scientific Inc. has Changed its Ticker to IVRN from HCYT	23-07-10	CI
H-CYTE, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-22	CI
H-CYTE, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	23-05-10	CI
H-CYTE, Inc. Auditor Raises 'Going Concern' Doubt	23-05-09	CI
H-CYTE, INC. : Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Unregistered Sale of Equity Securities, Financial Statements and Exhibits (form 8-K)	23-04-18	AQ
H-CYTE, Inc. announced that it expects to receive $0.135 million in funding	23-04-11	CI
H-CYTE, INC. : Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Unregistered Sale of Equity Securities, Financial Statements and Exhibits (form 8-K)	23-03-02	AQ
H-CYTE, Inc. announced that it expects to receive $0.3 million in funding	23-02-23	CI
H-CYTE Completes Acquisition of SkinDisc™ Regenerative Tissue Kit from Scion Solutions, LLC	22-12-29	AQ
H-CYTE, Inc. (OTCQB: HCYT) completed the acquisition of SkinDisc from Tanya Rhodes, Brock Liden, Spencer T Brown and Spencer T Brown.	22-12-28	CI
H-CYTE, INC. : Entry into a Material Definitive Agreement, Unregistered Sale of Equity Securities, Financial Statements and Exhibits (form 8-K)	22-12-28	AQ
H-CYTE, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)	22-11-14	AQ
H-CYTE, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-11-14	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

All News Innoveren Scientific Inc.

Equities

IVRN

US4041243076

All News

Filters